Cargando…
Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension
Objective To assess the ocular effects and safety profile of chronic sildenafil oral dosing in patients with pulmonary arterial hypertension. Design 12 week, double masked, randomised, placebo controlled, phase III trial with open label extension. Setting 53 institutions worldwide. Participants 277...
Autores principales: | Wirostko, Barbara M, Tressler, Charles, Hwang, Lie-Ju, Burgess, Gary, Laties, Alan M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283528/ https://www.ncbi.nlm.nih.gov/pubmed/22354598 http://dx.doi.org/10.1136/bmj.e554 |
Ejemplares similares
-
Why sildenafil and sildenafil citrate monohydrate crystals are not stable?
por: Sawatdee, Somchai, et al.
Publicado: (2015) -
Sildenafil Citrate in Fetal Growth Restriction
por: Panda, Subrat, et al.
Publicado: (2014) -
Peripheral Symmetrical Gangrene Treated with Sildenafil Citrate
por: Gandhi, Vijay, et al.
Publicado: (2012) -
Fixed Drug Eruption Caused by Sildenafil Citrate
por: Choi, Sun Young, et al.
Publicado: (2017) -
Ocular perfusion pressure and color Doppler imaging of the external ophthalmic artery of rabbits treated with sildenafil citrate
por: Costa, Ana Paula Araujo, et al.
Publicado: (2016)